Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a...

por Stalder, Grégoire, Suffiotti, Madeleine, Segot, Amandine, Noto, Alessandra, Pantaleo, Giuseppe, Spertini, Olivier, Obeid, Michel
Publicado 2022

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP

por Segot, Amandine, Adler, Marcel, Aliotta, Alessandro, Matthey‐Guirao, Elena, Nagler, Michael, Bertaggia Calderara, Debora, Grandoni, Francesco, Gomez, Francisco J., Alberio, Lorenzo
Publicado 2022

Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation

por Boutin, Laetitia, Arnautou, Pierre, Trignol, Aurélie, Ségot, Amandine, Farge, Thomas, Desterke, Christophe, Soave, Sabrina, Clay, Denis, Raffoux, Emmanuel, Sarry, Jean-Emmanuel, Malfuson, Jean-Valère, Lataillade, Jean-Jacques, Le Bousse-Kerdilès, Marie-Caroline, Anginot, Adrienne
Publicado 2020